U.S. markets closed
  • S&P 500

    3,841.94
    +73.47 (+1.95%)
     
  • Dow 30

    31,496.30
    +572.16 (+1.85%)
     
  • Nasdaq

    12,920.15
    +196.68 (+1.55%)
     
  • Russell 2000

    2,192.21
    +45.29 (+2.11%)
     
  • Crude Oil

    66.28
    +2.45 (+3.84%)
     
  • Gold

    1,698.20
    -2.50 (-0.15%)
     
  • Silver

    25.30
    -0.17 (-0.65%)
     
  • EUR/USD

    1.1925
    -0.0054 (-0.45%)
     
  • 10-Yr Bond

    1.5540
    +0.0040 (+0.26%)
     
  • GBP/USD

    1.3828
    -0.0066 (-0.47%)
     
  • USD/JPY

    108.3820
    +0.4060 (+0.38%)
     
  • BTC-USD

    48,438.52
    +339.51 (+0.71%)
     
  • CMC Crypto 200

    982.93
    +39.75 (+4.21%)
     
  • FTSE 100

    6,630.52
    -20.36 (-0.31%)
     
  • Nikkei 225

    28,864.32
    -65.78 (-0.23%)
     

S.African drugmaker Aspen sells thrombosis drug unit to Mylan

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

JOHANNESBURG, Sept 8 (Reuters) - South African drugmaker Aspen Pharmacare said on Tuesday it had sold its European thrombosis business to U.S. pharmaceutical company Mylan for almost 642 million euros ($758.65 million).

"The proceeds from the transaction will be used to reduce the group's debt," Aspen said in a statement, adding that Mylan will pay 263.2 million euros on completion of the deal and the balance in June 2021. ($1 = 0.8462 euros) (Reporting by Emma Rumney Editing by Tanisha Heiberg)